Arsenic binds to nuclear transport factors and disrupts nucleocytoplasmic transport
Open Access
- 15 August 2025
- journal article
- Published by The Company of Biologists in Journal of Cell Science
- Vol. 138 (16)
Abstract
Human exposure to arsenicals is associated with devastating diseases such as cancer and neurodegeneration. At the same time, arsenic-based drugs are used as therapeutic agents. The ability of arsenic to directly bind to proteins is correlated with its toxic and therapeutic effects, highlighting the importance of elucidating arsenic–protein interactions. In this study, we took a proteomic approach and identified 174 proteins that bind to arsenic in Saccharomyces cerevisiae. Proteins involved in nucleocytoplasmic transport were markedly enriched among the arsenic-binding proteins, and we demonstrate that arsenic binding to nuclear import factors results in their relocation from the nuclear envelope and subsequent aggregation in the cytosol. Similarly, nuclear pore proteins that make up the nuclear pore complex mislocalized and aggregated in arsenic-exposed cells. Consequently, arsenic was shown to inhibit nuclear protein import and export. We propose a model in which arsenic binding to nuclear transport factors leads to their mislocalization and aggregation, which disrupts nucleocytoplasmic transport and causes arsenic sensitivity.Keywords
Funding Information
- National Institutes of Health (R01GM138413, R01GM48533)
- Cancerfonden (211-865)
- Vetenskapsrådet (2019-4004, 2018-03577)
- Stiftelsen Bengt Lundqvists Minne
- Sven och Dagmar Saléns stiftelse
- Olle Engkvists Stiftelse (216-0452)
- University of Gothenburg
This publication has 80 references indexed in Scilit:
- Mechanisms of genotoxicity and proteotoxicity induced by the metalloids arsenic and antimonyCellular and Molecular Life Sciences, 2023
- Recent progress in analytical strategies of arsenic-binding proteomes in living systemsAnalytical and Bioanalytical Chemistry, 2023
- Yeast chaperones and ubiquitin ligases contribute to proteostasis during arsenite stress by preventing or clearing protein aggregatesFEBS Letters, 2023
- Arsenic in medicine: past, present and futureBioMetals, 2022
- Unification of Protein Abundance Datasets Yields a Quantitative Saccharomyces cerevisiae ProteomeCell Systems, 2018
- UCSF ChimeraX: Meeting modern challenges in visualization and analysisProtein Science, 2017
- p‐Azidophenylarsenoxide: An Arsenical “Bait” for the In Situ Capture and Identification of Cellular Arsenic‐Binding ProteinsAngewandte Chemie International Edition, 2016
- Identification of arsenic-binding proteins in human breast cancer cellsCancer Letters, 2007
- A suite of Gateway® cloning vectors for high‐throughput genetic analysis in Saccharomyces cerevisiaeYeast, 2007
- Computer Visualization of Three-Dimensional Image Data Using IMODJournal of Structural Biology, 1996